WFH World Bleeding Disorders Registry (WBDR) Steering Committee: 2024 to 2026
The WFH World Bleeding Disorders Registry (WBDR) Steering Committee oversees the development and implementation of the WBDR and activities related to the collection, management, and analysis of data collected through […]
von Willebrand Disease and Rare Bleeding Disorders Committee: 2024 to 2026
The von Willebrand Disease and Rare Bleeding Disorders (VWD-RBD) Committee’s mandate is to develop and recommend activities for WFH programming to enhance access to treatment for von Willebrand disease (VWD), […]
Psychosocial Committee: 2024 to 2026
The objective of the WFH Psychosocial Committee is to improve the quality of care—and quality of life—of people with bleeding disorders. This is achieved by making psychosocial care an integral […]
Nurses Committee: 2024 to 2026
The vision of the WFH Nurses Committee is to improve the quality of care of patients with hemophilia and other bleeding disorders throughout the world. This is achieved by enhancing […]
Laboratory Science Committee: 2024 to 2026
The WFH Laboratory Science Committee raises awareness of standards in the diagnosis of hemophilia and other inherited bleeding disorders. Chair Silmara Montalvao Brazil Vice-chair Annette Bowyer U.K. Members Dong Chen […]
Dental Committee: 2024 to 2026
The aim of the Dental Committee is to raise awareness of the need for good oral healthcare in the hemophilia community and to develop strategies to deliver it to all […]
Data and Demographics Committee: 2024 to 2026
The WFH Data and Demographics Committee oversees WFH activities related to the collection, management, and analysis of data collected through the Annual Global Survey. The Data and Demographics Committee includes […]
Coagulation Product Safety, Supply, and Access Committee: 2024 to 2026
The WFH Coagulation Product Safety, Supply, and Access (CPSSA) Committee oversee all WFH activities related to safety and supply issues. It includes patients, clinicians, and regulators. Chair Radoslaw Kaczmarek Poland […]
Musculoskeletal Committee: 2024 to 2026
The role of the WFH Musculoskeletal Committee is to provide education, exchange treatment experiences, and promote research and training on the management of musculoskeletal complications in hemophilia. As well as […]
Medical Advisory Board: 2024 to 2026
The Medical Advisory Board (MAB) is responsible for recommending policy on specific medical and clinical issues to the Board of Directors of the WFH. Members include all medical members of […]